Влияние антигипертензивной терапии на риск развития деменции и когнитивных расстройств. Результаты исследования HYVET-COG

лица старческого возраста, когнитивная функция, деменция, антигипертензивная терапия, индапамид

1. Bulpitt C., Rajkumar C., Beckett N. Hypertension in the elderly // Clinician's manual. - London, 1999. - 1200 p.

2.

3. Bulpitt C., Fletcher A., Amery A. et al. The hypertension in the very Elderly Trial (HYVET). Rational, methology and comparison with previous trials // Drugs Aging. - 1994. - Vol. 5. - P. 171-183.

4.

5. Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in community population aged 75 years and older // Arch. Neurol. - 1999. - Vol. 56, № 8. - P. 991-996.

6.

7. Amery A., Birkenhager W., Brixko P. et al. Mortality and morbidity results from the European working party on high blood pressure in the Elderly trial // Lancet. - 1985. - Vol. 1, № 8442. - P. 1349-1354.

8.

9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) // JAMA. - 1991. - Vol. 265. - P. 3255-3264.

10.

11. Poon I.O. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment // Pharmacotherapy. - 2008. - Vol. 28, № 3. - P. 366-375.

12.

13. Whitmer R.A., Sidney S., Selby J. et al. Midlife cardiovascular risk factors and risk of dementia in late life // Neurology. - 2005. - Vol. 64. - P. 277-281.

14.

15. Jellinger K., Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimers disease // J. Neurol. - 2003. - Vol. 250. - P. 1050-1055.

16.

17. Lithell H., Hansson L., Skoog I. et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial // J. Hypertens. - 2003. - Vol. 21. - P. 875-886.

18.

19. Forette F., Seux M.L., Staessen J.A. et al. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study // Arch. Intern. Med. - 2002. - Vol. 162. - P. 2046-2052

20.

21. Tzourio C., Anderson C., Chapman N. et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease // Arch. Intern. Med. - 2003. - Vol. 163. - P. 1069-1075.

22.

23. Gueyffier F., Bulpitt C., Boissel J.-P. et al. for the INDANA Group. Antihypertensive drugs in the very old people: a subgroup meta-analysis of randomized controlled trials // Lancet. - 1999. - Vol. 353. - P. 793−796.

24.

25. Dahlцf B, Hansson L , Lindholm L.H ., Scherstйn B, Ekbom T , Wester P.O . Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992 // Clin. Exp. Hypertens <javascript:AL_get(this, 'jour', 'Clin Exp Hypertens.');>. - 1993. - Vol. 15, № 6. - P. 925−939.

26.

27. Hansson L., Lindholm L.H., Ekbom T. et al. Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study // Lancet. - 1999. - Vol. 354, № 9192. - P. 1751-1756.

28.

29. Gosse Ph., Sheridan D., Zannad F. et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE Study // J. Hypertens. - 2000. - Vol. 18. - P. 1465−1475.

30.

31. Marre M., Garcia-Puig J., Kokot F. et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR study // J. Hypertens. - 2004. - Vol. 22. - P. 1613−1622.

32.

33. London G., Asmar R., Schmieder R., Calvo C. Antihypertensive efficacy of Indapamide SR vs candesartan and amlodipine in hypertensive patients in isolated hypertensive patients // Am. J. Hypertens. - 2004. - Vol. 17. - P. 183A.

34.

35. Fournier A., Messerli F., Achard J., Fernandez L. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomised clinical trials // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1343-1347.

36.

37. Kivipelto M., Helkala E.L., Laakso M.P. et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease // Ann. Intern. Med. - 2002. - Vol. 137. - P. 149-155.

38.

39. Reitz C., Tang M.X., Luchsinger J. et al. Relation of plasma lipids to Alzheimer disease and vascular dementia // Arch. Neurol. - 2004. - Vol. 61. - P. 705-714.

40.

41. Mielke M.M., Zandi P.P., Sjogren M. et al. High total cholesterol levels in late life associated with a reduced risk of dementia // Neurology. - 2005. - Vol. 64. - P. 1689-1695.

42.

43. Wilson R.S., Hebert L.E., Scherr P.A. et al. Educational attainment and cognitive decline in old age // Neurology. - 2009. - Vol. 72, № 5. - P. 460-465.

44.

45. Seliger S.L., Siscovick D.S., Stehman-Breen C.O. et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study // J. Am. Soc. Nephrol. -2004. - Vol. 15, № 7. - P. 1904-1911.

46.

47. Hooren S.A., Valentijn A.M., Bosma H. et al. Cognitive functioning in healthy older adults aged 64-81: a cohort study into the effects of age, sex, and education // Neuropsychol. Dev. Cogn. Aging Neuropsychol. Cogn. - 2007. - Vol. 14, № 1. - P. 40-54.

48.

49. Azad N.A., Bugami A.L., Loy-English I. Gender differences in dementia risk factors // Gend. Med. - 2007. - Vol. 4, № 2. - P. 120-129.

50.